An examination of layoffs in pharmaceutical and biotechnology companies in Q3 shows that as the summer progressed, the number ...
With worldwide pharmaceutical sales at around $1 trillion ... with Abbott and Bristol-Myers Squibb jumping up the charts compared with last year’s first quarter. It’s several years since ...
Hosted on MSN10mon
Orchid Pharma charts out growth planOrchid Pharma, which is seeing a turnaround under its new promoter Dhanuka Group, aspires to be a fully integrated powerhouse of cephalosporin antibiotics, the company’s top executive said.
Feb 19 (Reuters) - An index of Indian pharmaceutical company shares (.NIPHARM), opens new tab slid 2% to its lowest level in seven months on Wednesday after U.S. President Donald Trump said he ...
A major pharmaceutical company that has invested heavily in North Carolina is planning multiple new factories in the U.S. STORY HIGHLIGHTS Eli Lilly plans $27 billion U.S. expansion, will create ...
Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic ...
Avalon Pharma profit jumps 72% to SAR 35M in 9M 2024; Q3 at SAR 3.9M 9 M 2024 Avalon Pharma’s profit rises 78% to SAR 31.2M in H1 2024; Q2 at SAR 21.8M 6 M 2024 Avalon Pharma turns to profit of SAR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results